SG Americas Securities’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Buy |
134,404
+127,126
| +1,747% | +$3.52M | 0.02% | 500 |
|
|
2025
Q1 | $162K | Sell |
7,278
-10,692
| -59% | -$238K | ﹤0.01% | 2395 |
|
|
2024
Q4 | $355K | Buy |
+17,970
| New | +$355K | ﹤0.01% | 1442 |
|
|
2024
Q3 | – | Sell |
-69,226
| Closed | -$1.29M | – | 3054 |
|
|
2024
Q2 | $1.29M | Buy |
69,226
+50,066
| +261% | +$934K | 0.01% | 1086 |
|
|
2024
Q1 | $378K | Buy |
19,160
+1,435
| +8% | +$28.3K | ﹤0.01% | 1393 |
|
|
2023
Q4 | $311K | Buy |
+17,725
| New | +$311K | ﹤0.01% | 1628 |
|
|
2023
Q2 | – | Sell |
-15,619
| Closed | -$168K | – | 2391 |
|
|
2023
Q1 | $168K | Buy |
+15,619
| New | +$168K | ﹤0.01% | 2328 |
|
|
2021
Q4 | – | Sell |
-18,551
| Closed | -$211K | – | 3169 |
|
|
2021
Q3 | $211K | Buy |
+18,551
| New | +$211K | ﹤0.01% | 2941 |
|
|
2021
Q2 | – | Sell |
-5,694
| Closed | -$105K | – | 2689 |
|
|
2021
Q1 | $105K | Buy |
+5,694
| New | +$105K | ﹤0.01% | 2788 |
|
|
2020
Q4 | – | Sell |
-94,543
| Closed | -$1.45M | – | 2852 |
|
|
2020
Q3 | $1.45M | Buy |
94,543
+56,324
| +147% | +$863K | 0.01% | 797 |
|
|
2020
Q2 | $974K | Buy |
+38,219
| New | +$974K | 0.01% | 1209 |
|